Position in CCCC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,871,288
+$3,303,532 QoQ
Shares Held
828,970
+284.0% QoQ
Ownership
0.674%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Derivatives in CCCC
reported options exposure · as of Jun 30, 2022CallValue
$226,200
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. CCCC ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in CCCC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,871,288 | 828,970 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $567,756 | 215,877 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $100,755 | 52,752 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $136,861 | 61,650 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $817,995 | 572,026 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,396,432 | 872,770 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,728,265 | 757,852 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,904,261 | 334,081 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,867,025 | 404,118 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,691,850 | 696,677 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,572,818 | 278,375 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $598,192 | 321,609 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $741,955 | 269,802 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $510,720 | 162,650 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,594,297 | 270,220 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,780,483 | 317,045 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,617,782 | 347,186 | Shares | Defined | 2022-08-10 | |
| 2022-06-30 | $226,200 | 30,000 | Call | Defined | 2022-08-10 | |
| 2022-03-31 | $7,995,561 | 329,578 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,038,095 | 342,798 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,647,331 | 417,353 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,187,954 | 401,373 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,707,580 | 262,438 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,336,720 | 100,716 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||